Make sure this course is right for you.
Get unbiased reviews and personalized recommendations.
About the course
A strong ethical reputation is critical for pharmaceutical companies to succeed. But how do you build and sustain a culture of integrity that creates trust among customers, shareholders, and employees?
Enable managers at your pharmaceutical company to develop an understanding of ethical decision making—and how to confront ethical issues in the workplace—with the online Ethics and the Pharmaceutical Industry certificate.
This certificate is designed for anyone in a management position—from newly appointed managers to experienced high-level managers—within the pharmaceutical industry.
Forward-thinking companies understand that establishing a culture of integrity is not only compatible with strong business performance, it is crucial to maintaining a competitive advantage. Using lessons from these companies and cutting-edge research, the Ethics and the Pharmaceutical Industry online certificate program coaches managers to lead in a way that fosters corporate values, promotes a culture of integrity, reduces ethics and compliance risks, and drives sustained success—all in a flexible, interactive, and peer-focused learning environment.
Participants who earn the certificate will understand:
- the risk-related imperative and strategic value of getting beyond ethics and compliance to a culture of integrity
- how ethical decisions are made and how those decisions translate into ethical behavior
- key legal and ethical issues confronting the pharmaceutical industry
- the impact of ethical conduct that extends beyond check-the-box, compliance-driven objectives
- the crucial paradox of sincerity—that the biggest payoff for ethical conduct occurs when the pursuit of ethics is done for its own good
- how to raise ethical issues in the workplace
This 12-week certificate offers a training model designed for seven industries so that materials relevant to a particular industry are emphasized. The online, asynchronous training model is divided into four, three-week modules. Participants must complete all four modules to earn the Ethics and the Pharmaceutical Industry certificate.
Participants can expect to spend about three hours per week on this course. This program will include discussion boards, where you can interact with faculty and other participants, and a series of prerecorded video lectures. There will be deadlines for individual assignments throughout the 12-week period.
Module 1: Ethical Decision-Making Models and the Pharmaceutical Industry
- A Decision-Making Model in Corporate Ethics Chapter 1: Ethics Vignettes
- Case Study Vignette: A Threshold Legal Case: Chapter 2: Ethics Vignettes: Dodge v Ford
- Case Study Vignette: A Threshold Legal Case: Chapter 2: Ethics Vignettes: Shlensky v Wrigley
- Case Study Vignette: Cognitive Biases in Decision Making; Curbing Corruption: Ethics Unwrapped: GSK in China
Module 2: Continued Vignettes in the Pharmaceutical Industry
- Case Study Vignette: Chapter 2: Cognitive Biases in Decision-Making; Ethics Vignettes: Labzda v Purdue Phrarma
- Case Study Vignette: Chapter 2: Cognitive Biases in Decision-Making; Ethics Vignettes: Alliance for Better Access to Developmental Drugs V McClellan
- Case Study Vignette: Chapter 2: Ethics Vignettes: J&J to Pay More Than $2 Billion to Resolve Criminal & Civil Investigations
- Case Study Vignette: Cognitive Biases; Your Own Story
Module 3: CEO Perspectives, Within and Outside of the Pharmaceutical Industry
- Ethical Leadership: What CEOS have to Say: The Sincerity Edge
- Building Trustworthy Corporate Culture: The Sincerity Edge
- 12 Steps to Build Ethical Leadership: The Sincerity Edge
- Case Study Vignette: Ethics Unwrapped: OxyContin: Whale Watching
Module 4: Impact of Ethical Business Conduct
- Unexpected Payoffs for Ethical Corporate Cultures Chapter 3: Ethics Vignettes
- Case Study Vignette: Clinical Drug Trials
- Opportunity for written reflection on levels of ethical development arising out of the connection of the participant’s business experience and their preferences in music, sports, and film.
- Opportunity for individual choice of research on a topic of interest
Timothy L. Fort, PhD and JD, holds the Eveleigh Professorship in Business Ethics and is a professor of business law and ethics at the Kelley School of Business. Fort has written nearly 80 articles and 15 books including two winners of the Best Book Award from the Academy of Management for Social...
Because of COVID-19, many providers are cancelling or postponing in-person programs or providing online participation options.
We are happy to help you find a suitable online alternative.